Delaware Legislature Debates Dueling Hemp THC Regulation Bills

Delaware lawmakers are racing against a tight legislative deadline to pass hemp-derived THC regulations, but they can't agree on how strict those rules should be.

Two competing bills are now under consideration with just over a month remaining in the state's legislative session. The proposals take markedly different approaches to regulating delta-8 THC and similar intoxicating cannabinoids that have proliferated in gas stations, smoke shops, and convenience stores across Delaware since the 2018 Farm Bill federally legalized hemp.

"I know these products are safe. I know they are tested, because if they weren't, I wouldn't carry them in my stores," one retailer told lawmakers, defending the current hemp market.

The Competing Approaches

The legislative split reflects a broader tension playing out in statehouses nationwide. Delaware legalized adult-use cannabis in 2023, but hemp-derived products containing delta-8, delta-10, and THC-O remain in a regulatory gray zone—legally sold under federal hemp law but operating outside the state's licensed cannabis framework.

One bill would impose stricter oversight aligned with Delaware's regulated cannabis market, potentially requiring hemp retailers to obtain licenses and meet testing standards similar to dispensaries. The competing proposal takes a lighter touch, focusing on age restrictions and labeling requirements while allowing the existing hemp market to continue largely as-is.

The debate comes as Delaware's licensed cannabis retailers argue they face unfair competition from untaxed, less-regulated hemp products. Meanwhile, hemp businesses warn that overly restrictive rules could wipe out their industry overnight.

What's At Stake

At least 20 states have moved to regulate or restrict intoxicating hemp products since they began flooding the market in 2020. Some states like Minnesota have integrated hemp-derived THC into their broader cannabis frameworks. Others like Arkansas have banned delta-8 and similar compounds outright.

Delaware's situation is complicated by timing. The state only began licensing adult-use cannabis dispensaries this year, meaning the regulated market is still finding its footing. Hemp products have been available far longer and command significant shelf space at retailers who invested in inventory and customer relationships.

Industry observers note that Delaware's approach could influence neighboring states still grappling with the same questions. Maryland legalized adult-use cannabis in 2023 but hasn't comprehensively addressed hemp-derived intoxicants. Pennsylvania's medical-only market faces similar hemp competition.

The Clock Is Ticking

Delaware's General Assembly typically adjourns by the end of June, giving lawmakers roughly five weeks to reconcile the competing bills or choose one approach over the other. If they fail to act, hemp-derived THC products will continue operating in their current regulatory limbo.

That uncertainty frustrates both sides. Licensed cannabis operators want a level playing field. Hemp retailers want clarity on whether their businesses have a future in Delaware.

The outcome will likely hinge on whether lawmakers prioritize consumer protection concerns—unregulated products reaching minors, inconsistent potency, questionable testing—or economic arguments about preserving existing hemp businesses and avoiding market disruption.

Several states that initially banned delta-8 have since reversed course after facing industry pushback and recognizing the difficulty of enforcement. Delaware lawmakers appear aware of those cautionary tales as they navigate their own path forward.

---

This article is based on original reporting by www.marijuanamoment.net.